ProPhase Labs, Inc. (PRPH) analyst actions
Rating and price-target actions on PRPH in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PRPH overview →
1 measured PRPH analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative | Press release | -1.72% | -8.05% |
Keep exploring
More PRPH: earnings → · SEC filings → · PRPH overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Daxor Corporation - Closed End Fund (DXR) | 200 | 0.00% | 50% |
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
| Inogen, Inc (INGN) | 197 | +0.31% | 60% |
| Protalix BioTherapeutics, Inc. (DE) (PLX) | 197 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.